EUZ Stock Overview
Manufactures and sells isotope technology components worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for EUZ from our risk checks.
Eckert & Ziegler SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €37.14 |
| 52 Week High | €50.05 |
| 52 Week Low | €32.74 |
| Beta | 1.33 |
| 11 Month Change | -16.99% |
| 3 Month Change | -15.40% |
| 1 Year Change | -5.35% |
| 33 Year Change | -62.08% |
| 5 Year Change | -23.42% |
| Change since IPO | 499.03% |
Recent News & Updates
Eckert & Ziegler SE's (ETR:EUZ) Share Price Could Signal Some Risk
Aug 08
Does Eckert & Ziegler (ETR:EUZ) Have A Healthy Balance Sheet?
Jul 17Recent updates
Eckert & Ziegler SE's (ETR:EUZ) Share Price Could Signal Some Risk
Aug 08Does Eckert & Ziegler (ETR:EUZ) Have A Healthy Balance Sheet?
Jul 17Why We Think Eckert & Ziegler SE's (ETR:EUZ) CEO Compensation Is Not Excessive At All
Jun 20Investors Met With Slowing Returns on Capital At Eckert & Ziegler (ETR:EUZ)
Jun 05Is Now An Opportune Moment To Examine Eckert & Ziegler SE (ETR:EUZ)?
May 13Eckert & Ziegler SE (ETR:EUZ) Investors Are Less Pessimistic Than Expected
Apr 27Here's Why Eckert & Ziegler (ETR:EUZ) Can Manage Its Debt Responsibly
Apr 12Slowing Rates Of Return At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Leave Little Room For Excitement
Mar 06What Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) P/E Is Not Telling You
Jan 04Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Has A Pretty Healthy Balance Sheet
Dec 20Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Hasn't Managed To Accelerate Its Returns
Nov 15What Is Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) Share Price Doing?
Oct 01A Look At The Intrinsic Value Of Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)
Aug 22These 4 Measures Indicate That Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is Using Debt Reasonably Well
Jul 16Is It Time To Consider Buying Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Jun 22The Return Trends At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Look Promising
May 17Is Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ) Potentially Undervalued?
Mar 20Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Returns Have Hit A Wall
Jan 24We Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Can Stay On Top Of Its Debt
Oct 27Is It Time To Consider Buying Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Oct 05Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Has Some Way To Go To Become A Multi-Bagger
Aug 21Is Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) A Risky Investment?
Jul 21Is There Now An Opportunity In Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Jun 13Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Will Pay A Larger Dividend Than Last Year At €0.50
May 13Returns At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Are On The Way Up
May 09Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Dividend Will Be Increased To €0.50
Apr 24Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Dividend Will Be Increased To €0.50
Mar 27Do Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Earnings Warrant Your Attention?
Mar 25When Should You Buy Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Feb 17Investors Will Want Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Growth In ROCE To Persist
Jan 31Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Deserve Your Attention Today
Dec 13Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Returns On Capital Are Heading Higher
Nov 01Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Deserve Your Attention Today
Sep 14Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Have The Makings Of A Multi-Bagger
Jul 29Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is An Interesting Stock
Jun 11Shareholder Returns
| EUZ | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -6.2% | -0.4% | -0.4% |
| 1Y | -5.4% | -7.1% | 7.1% |
Return vs Industry: EUZ matched the German Medical Equipment industry which returned -6.1% over the past year.
Return vs Market: EUZ underperformed the German Market which returned 7.8% over the past year.
Price Volatility
| EUZ volatility | |
|---|---|
| EUZ Average Weekly Movement | 5.1% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: EUZ has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: EUZ's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,143 | Harald Hasselmann | www.ezag.com |
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services.
Eckert & Ziegler SE Fundamentals Summary
| EUZ fundamental statistics | |
|---|---|
| Market cap | €774.20m |
| Earnings (TTM) | €35.90m |
| Revenue (TTM) | €277.72m |
21.6x
P/E Ratio2.8x
P/S RatioIs EUZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EUZ income statement (TTM) | |
|---|---|
| Revenue | €277.72m |
| Cost of Revenue | €144.30m |
| Gross Profit | €133.43m |
| Other Expenses | €97.52m |
| Earnings | €35.90m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 27, 2025
| Earnings per share (EPS) | 1.72 |
| Gross Margin | 48.04% |
| Net Profit Margin | 12.93% |
| Debt/Equity Ratio | 8.6% |
How did EUZ perform over the long term?
See historical performance and comparison